:

Chi Phuong Nguyen1,2,3, Maarten M H Lahr4,2, Durk-Jouke van der Zee1,2

  • 1Department of Operations, Faculty of Economics and Business (C.P.N., D.-J.v.d.Z., E.B.), University of Groningen, the Netherlands.

Stroke
|August 12, 2024
PubMed
概括

在大血管阻塞中风的内静脉高血位素在内血管血栓切除术 (EVT) 之前,在荷兰,在较低的门下是不具有成本效益的. 然而,在较高的值下,它可能具有成本效益,结果因试验人群而异.